Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAF1 | P04049 | 1/20 | 0.37 |
| ▸ | SYK | P43405 | 9/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.34 |
| ▸ | NPY2R | P49146 | 2/20 | 0.33 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.33 |
| ▸ | CTPS1 | P17812 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.32 |
| ▸ | SMARCA4 | P51532 | 1/20 | 0.32 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
| ▸ | TGFBR2 | P37173 | 1/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL76886 | 1.00 | RAF1 (0.37) | RAF1SYKS1PR1NPY2RCALCRL | |
| SCHEMBL86469 | 0.91 | RAF1 (0.39) | RAF1SYKS1PR1NPY2RCTPS1 | |
| SCHEMBL78158 | 0.91 | RAF1 (0.39) | RAF1SYKS1PR1NPY2RCTPS1 | |
| SCHEMBL78157 | 0.91 | RAF1 (0.39) | RAF1SYKS1PR1NPY2RCTPS1 | |
| SCHEMBL86468 | 0.86 | ALDH1A1 (0.40) | RAF1SYKCALCRLGAA | |
| SCHEMBL76887 | 0.86 | ALDH1A1 (0.40) | RAF1SYKCALCRLGAA | |
| SCHEMBL86090 | 0.85 | CCNT1 (0.38) | RAF1SYKCALCRL | |
| SCHEMBL86447 | 0.84 | RAF1 (0.39) | RAF1SYKCALCRLGAASMARCA2 | |
| SCHEMBL86044 | 0.83 | BRAF (0.41) | RAF1SYKTGFBR1TGFBR2 | |
| SCHEMBL86092 | 0.81 | LMNA (0.48) | CALCRLTGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8129396-B2 | 2-[1H-benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors | TELIK, INC. (US) | 2012-03-06 | — | — | US | claimed |